Free Republic 3rd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $13,038
16%  
Woo hoo!! And we're now over 16%!! Thank you all very much!! God bless.

Keyword: roivant

Brevity: Headers | « Text »
  • Is Vivek Ramaswamy the Biz Whiz He Claims to Be?

    09/08/2023 9:01:26 PM PDT · by Reno89519 · 33 replies
    The Messenger Business ^ | September 8, 2023 | Ben White
    Vivek Ramaswamy, the fast-talking, Ivy League-educated, telegenic political phenom thrills Republican voters, infuriates his presidential primary opponents and styles himself as an entrepreneurial “scientist” with a glittering business background and hundreds of millions of dollars to dump into his out-of-nowhere campaign for the White House. But a review of Ramaswamy’s career – marked by the hyping of a failed Alzheimer's drug, giant payouts when other investors got burned, lawsuits alleging pressure to break securities laws and more – reveals a businessperson whose true liquid net worth is unknown and whose track record as a successful entrepreneur shows limited value creation...
  • Paul & Daisy Soros Fellow Vivek Ramaswamy’s Roivant Sciences Develops Clinical Stage Antibody to Prevent and Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19 (2020)

    05/26/2023 9:44:14 AM PDT · by dynachrome · 15 replies
    soros fellowship for new americans ^ | 3-18-20 | soros fellowship for new americans
    Roivant Sciences announced today that it is working with regulators in the United States and around the world to advance the clinical development of Gimsilumab, an anti-body that could prevent and treat acute respiratory distress syndrome (ARDS), which has been widely connected to the COVID-19 virus. 2011 Paul & Daisy Soros Fellow Vivek Ramaswamy, the child of immigrants from India, is the CEO and founder of Roivant Sciences. “Gimsilumab is a clinical-stage, fully human monoclonal antibody targeting granulocyte-macrophage colony stimulating factor (GM-CSF). GM-CSF is a pro-inflammatory cytokine found to be up-regulated in the serum of COVID-19 patients according to recent...